Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Isenberg

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Rheumatology (Oxford, England)|September 22, 2014
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?Dennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Rheumatology International|December 26, 2016
Physical activity but not sedentary activity is reduced in primary Sjögren's syndromeWan-Fai Ng, Ariana Miller, Simon J Bowman, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Swiss Medical Weekly|February 15, 2018
Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome RegistryAlexandre Dumusc, Wan-Fai Ng, Katherine James, et al.
Rheumatology (Oxford, England)|September 22, 2014
Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?Dennis Lendrem, Sheryl Mitchell, Peter McMeekin, et al.
Research and Practice in Thrombosis and Haemostasis|August 14, 2024
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trialPrabal Mittal, Rafael Gafoor, Zara Sayar, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Rheumatology International|December 26, 2016
Physical activity but not sedentary activity is reduced in primary Sjögren's syndromeWan-Fai Ng, Ariana Miller, Simon J Bowman, et al.
Annals of the Rheumatic Diseases|April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Clinical Pharmacology and Therapeutics|September 20, 2017
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative InitiativeRohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Clinical Pharmacology and Therapeutics|August 7, 2018
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered QuestionnairesNathalie Costedoat-Chalumeau, Frédéric Houssiau, Peter Izmirly, et al.
Rheumatology (Oxford, England)|October 30, 2015
Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome RegistryClare Oni, Sheryl Mitchell, Katherine James, et al.
Pageof 19